InvestorsHub Logo
Post# of 251798
Next 10
Followers 69
Posts 6152
Boards Moderated 0
Alias Born 11/26/2008

Re: oldberkeley post# 198029

Monday, 12/07/2015 2:16:15 PM

Monday, December 07, 2015 2:16:15 PM

Post# of 251798
STML -

Saw a Tweet suggesting that while the BPDCN results are good, the Acute Myeloid Leukemia (AML) data are not so great.

The concerns I have read even on BPDCN data are that even though early data looks good, the side effects limit the number of cycles of treatment a given patient can receive. Don't follow closely so don't know how valid those concerns are.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.